This information was published on 2022-01-12T08:36:59 for IP Right Registration Published.
| Field | Value |
| (210) | 2222950 |
| (220) |
26 Oct 2021
|
| (300) |
US, 17 May 2021, 90/714817
|
| (511) (510) |
Class 5
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives |
| (540) | VURZARRO |
| (550) | Word |
| (730) |
Johnson & Johnson
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.